Angiogenesis in symptomatic intracranial atherosclerosis -: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence

被引:40
作者
Arenillas, JF
Alvarez-Sabín, J
Montaner, J
Rosell, A
Molina, CA
Rovira, A
Ribó, M
Sánchez, E
Quintana, M
机构
[1] Vall Hebron Univ Hosp, Neurovasc Unit, Barcelona, Spain
[2] Vall Hebron Univ Hosp, Neurovasc Res Lab, Barcelona, Spain
[3] Vall Hebron Univ Hosp, Magnet Resonance Unit, Barcelona, Spain
关键词
angiogenesis; atherosclerosis; intracranial; endostatins; intracranial stenosis; vascular endothelial growth factor;
D O I
10.1161/01.STR.0000149617.65372.5d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Angiogenesis may be beneficial in chronic myocardial and limb ischemia, but its role in intracranial atherosclerosis remains unknown. We aimed to investigate the relationship between the pro-angiogenic vascular endothelial growth factor (VEGF) and the anti-angiogenic endostatin, and the extent and risk of recurrence of symptomatic intracranial atherosclerosis. Methods-Of a total of 94 consecutive patients with symptomatic intracranial stenoses, 40 fulfilled all inclusion criteria. Intracranial stenoses were confirmed by magnetic resonance angiography. Magnetic resonance imaging (MRI) including diffusion-weighted sequences was conducted. Plasmatic VEGF and endostatin were determined from blood samples obtained 3 months after stroke onset, and patients were followed-up thereafter. Results-A total of 144 intracranial stenoses were confirmed (median number per patient=3). Endostatin/VEGF ratio gradually augmented with the increasing number of intracranial stenoses (r=0.35, P=0.02). Diabetes mellitus (OR, 6.04; CI, 1.1 to 32.2; P=0.03) and a higher endostatin/VEGF ratio (OR, 15.7; CI, 2.2 to 112.3; P=0.006) were independently associated with a greater extent of intracranial atherosclerosis. During a median follow-up of 13 months, 8 patients (20%) experienced a new cerebral ischemic event. A higher baseline endostatin concentration was an independent predictor of new events (hazard ratio, 7.24; CI, 1.6 to 33.8; P=0.011) in a Cox regression model after adjustment for age, sex, number of stenotic vessels, and risk factors. Patients with a higher endostatin level had a lower survival free of new events (P=0.01, log-rank test). Conclusions-A predominance of the inhibitor endostatin within the endogenous angiogenic response is associated with a greater extent and risk of recurrence of symptomatic intracranial atherosclerosis, suggesting that angiogenesis may be beneficial in this condition.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 24 条
  • [1] High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis
    Arenillas, JF
    Molina, CA
    Chacón, P
    Rovira, A
    Montaner, J
    Coscojuela, P
    Sánchez, E
    Quintana, M
    Alvarez-Sabín, J
    [J]. NEUROLOGY, 2004, 63 (01) : 27 - 32
  • [2] Progression and clinical recurrence of symptomatic middle cerebral artery stenosis -: A long-term follow-up transcranial Doppler ultrasound study
    Arenillas, JF
    Molina, CA
    Montaner, J
    Abilleira, S
    González-Sánchez, MA
    Alvarez-Sabín, J
    [J]. STROKE, 2001, 32 (12) : 2898 - 2904
  • [3] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
    Baumgartner, I
    Pieczek, A
    Manor, O
    Blair, R
    Kearney, M
    Walsh, K
    Isner, JM
    [J]. CIRCULATION, 1998, 97 (12) : 1114 - 1123
  • [4] Vascular endothelial growth factor enhances atherosclerotic plaque progression
    Celletti, FL
    Waugh, JM
    Amabile, PG
    Brendolan, A
    Hilfiker, PR
    Dake, MD
    [J]. NATURE MEDICINE, 2001, 7 (04) : 425 - 429
  • [5] Chimowitz M, 2004, STROKE, V35, P235
  • [6] THE WARFARIN-ASPIRIN SYMPTOMATIC INTRACRANIAL DISEASE STUDY
    CHIMOWITZ, MI
    KOKKINOS, J
    STRONG, J
    BROWN, MB
    LEVINE, SR
    SILLIMAN, S
    PESSIN, MS
    WEICHEL, E
    SILA, CA
    FURLAN, AJ
    KARGMAN, DE
    SACCO, RL
    WITYK, RJ
    FORD, G
    FAYAD, PB
    [J]. NEUROLOGY, 1995, 45 (08) : 1488 - 1493
  • [7] Endostatin induces endothelial cell apoptosis
    Dhanabal, M
    Ramchandran, R
    Waterman, MJF
    Lu, H
    Knebelmann, B
    Segal, M
    Sukhatme, VP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) : 11721 - 11726
  • [8] Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury
    Hutter, R
    Sauter, BV
    Reis, ED
    Roque, M
    Vorchheimer, D
    Carrick, FE
    Fallon, JT
    Fuster, V
    Badimon, JJ
    [J]. CIRCULATION, 2003, 107 (12) : 1658 - 1663
  • [9] Issa R, 1999, LAB INVEST, V79, P417
  • [10] Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus
    Kornowski, R
    [J]. CORONARY ARTERY DISEASE, 2003, 14 (01) : 61 - 64